Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

7.99
Delayed Data
As of Jan 18
 -0.46 / -5.44%
Today’s Change
7.41
Today|||52-Week Range
15.55
-4.99%
Year-to-Date
No recent news for Bellicum Pharmaceuticals Inc.

Today’s Trading

Previous close8.45
Today’s open8.45
Day’s range7.87 - 8.50
Volume1,149,128
Average volume (3 months)480,598
Market cap$280.8M
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)-39.67%
Earnings growth (this year)-12.53%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.59%
P/E ratioNM
Price/Sales946.06
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp-0.08-4.02%
BTXBioTime Inc0.000.00%
NSTGNanoString Technolog...0.000.00%
SELBSelecta Biosciences ...+0.39+4.36%
Data as of 8:00pm ET, 01/18/2018

Financials

Next reporting dateMarch 13, 2018
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$388.0K
Annual profit (last year)-$69.2M
Net profit margin-17,845.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard A. Fair
Chief Financial Officer &
Treasurer
Alan A. Musso
Corporate headquarters
Houston, Texas

Forecasts